RxDoctor Payments DataLook up a doctor →

Alexander Weingarten, MD

Interventional Pain Medicine · Syosset, NYNPI 1558353078

Payments from drug & device makers

$42,520in general payments, 2019–2025

Across 1,888 payments — averaging $22.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • MDD US Operations, LLC$7K
  • West Therapeutics Development, LLC$5K
  • Collegium Pharmaceutical, Inc.$3K
  • AbbVie$3K
  • Scilex Pharmaceuticals Inc.$2K
  • Regeneron$2K
  • plus $20K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
MDD US Operations, LLC43$7,225
West Therapeutics Development, LLC5$5,056
Collegium Pharmaceutical, Inc.215$3,229
AbbVie(2 entities)189$3,078
Scilex Pharmaceuticals Inc.143$2,336
Regeneron1$1,860
Biodelivery Sciences International, Inc.141$1,798
Takeda Pharmaceuticals U.S.A., Inc.121$1,459
Biohaven Pharmaceuticals, Inc.15$1,425
Protega Pharmaceutials Inc16$1,360
Tersera Therapeutics LLC47$994
Redhill Biopharma Inc.98$962
Forte Bio-pharma LLC28$959
Pfizer98$929
Valinor Pharma, LLC97$887
Amgen(2 entities)56$869
Kowa Pharmaceuticals America, Inc.52$722
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC53$682
Nevro Corp.20$625
Daiichi Sankyo Inc.62$597
Eisai Inc.55$562
Arbor Pharmaceuticals, Inc.34$453
Merck26$396
Virtus Pharmaceuticals LLC26$389
Biohaven Pharmaceutical Holding Company Ltd.25$373
Azurity Pharmaceuticals, Inc.36$372
Almatica Pharma LLC22$285
IBSA Pharma Inc.9$263
Vertex13$245
Assertio Therapeutics, Inc.18$225
Zyla Life Sciences, Inc.22$171
USWM, LLC13$135
Orexo US, Inc.7$123
AstraZeneca7$122
Supernus Pharmaceuticals, Inc.7$108
Medtronic(2 entities)4$106
Boston Scientific5$101
Abbott5$93
Avanos Medical1$92
GRT US Holding, Inc.5$76
Sentynl Therapeutics, Inc.4$65
Indivior Inc.4$63
Bausch Health US, LLC4$62
Teva Pharmaceuticals USA, Inc.4$61
Idorsia Pharmaceuticals US Inc3$53
Pacira Pharmaceuticals Incorporated2$50
Lilly USA, LLC3$47
Vertical Pharmaceuticals, LLC3$45
Sun Pharmaceutical Industries Inc.3$41
Currax Pharmaceuticals LLC3$38
Hikma Pharmaceuticals USA2$33
Si-bone, Inc.2$30
Impel Pharmaceuticals Inc.2$30
ERMI LLC1$27
Globus Medical1$24
Johnson & Johnson1$18
Averitas Pharma Inc.1$18
Axsome Therapeutics, Inc.1$17
Pernix Therapeutics Holdings, Inc.1$16
Shionogi Inc1$15

How this compares

$42,520 in reported general payments places this provider in the 90th percentile of 132 interventional pain medicine providers in New York.

See all interventional pain medicine providers in New York

Medicare billing

Part B allowed, 2024
$937,765
Medicare patients
547
Services billed
30,145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Syosset

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →